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Abstract
Objectives: To obtain further information from members of the International Network of Agencies for
Health Technology Assessment (INAHTA) on the involvement of consumers in their programs. Methods:
A questionnaire for a survey was developed and sent to member agencies in November 2010. Survey
responses were compared with those from an earlier survey conducted in 2005. Results: Of the thirtythree agencies that provided responses, 67 percent involve consumers in some aspects of their health
technology assessment (HTA) programs, compared with 57 percent in 2005. As in the earlier survey, most
agencies reporting involvement have contact with consumer or patient organizations and a large minority
also involve individual consumers. Summaries of HTA reports that are intended to be easily understood
by consumers are prepared by 84 percent of the agencies, and 42 percent involve consumers in
dissemination of HTA material. In both areas, there was some increase from the levels previously
reported. Conclusions: The survey results suggest that there is a trend to increased involvement of
consumers by the INAHTA agencies in their programs but that the level of involvement remains relatively
limited. The manner of consumer participation varies between agencies. © Cambridge University Press
2012.
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Objectives: To obtain further information from members of the International Network of Agencies for Health Technology Assessment (INAHTA) on the involvement of consumers in their programs.
Methods: A questionnaire for a survey was developed and sent to member agencies in November 2010. Survey responses were compared with those from an earlier survey conducted in 2005.
Results: Of the thirty-three agencies that provided responses, 67 percent involve consumers in some aspects of their health technology assessment (HTA) programs, compared with 57 percent in
2005. As in the earlier survey, most agencies reporting involvement have contact with consumer or patient organizations and a large minority also involve individual consumers. Summaries of HTA
reports that are intended to be easily understood by consumers are prepared by 84 percent of the agencies, and 42 percent involve consumers in dissemination of HTA material. In both areas, there
was some increase from the levels previously reported.
Conclusions: The survey results suggest that there is a trend to increased involvement of consumers by the INAHTA agencies in their programs but that the level of involvement remains relatively
limited. The manner of consumer participation varies between agencies.
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The focus of health technology assessment (HTA) has often
been on stakeholders with major financial or operational responsibilities for health technologies, including government authorities, manufacturing industry, healthcare professionals, and the
health insurance industry. Patients and their families and carers
are also a key group with major interests in health technologies,
but until quite recently limited attention has been given to involving them in the HTA process (1). Criticism of the situation
included comment that health experts such as physicians, researchers, and economists largely dominate HTA decision making. This was seen as antithetical to the belief that acceptable
health decision making requires a process that is transparent,
not dominated by any particular interest and reflects the values
of all users (2).
In 2005 the International Network of Agencies for Health
Technology Assessment (INAHTA) prepared a review to help
consideration of how it might encourage more extensive involvement of patients in HTA (1). Involvement of patients in
formulation of questions, in assessments and in dissemination
had received some consideration in the literature, although there
was little that specifically related to the situation typically facing

HTA agencies of routinely producing and disseminating advice
for decision makers in health care, often with tight deadlines.
Some of the literature on involving consumers with health research provided some issues to consider (3–6). Common themes
included interaction of consumers and researchers, resources,
technical demands on consumers, training and education, nature and extent of consumer representation, matching consumer
information and information from the literature, time demands
and remuneration, and consumer impact on discussion and decisions.
One of the earlier reports of consumer involvement in HTA
gave details of approaches used in England by the National
Coordinating Centre for Health Technology Assessment (NCCHTA). These included attending prioritization meetings, and
commenting on research need for particular topics, research
proposals, and research reports (7).
Later that year members of INAHTA were surveyed to
obtain information on their involvement with consumers. The
term “consumers” was taken to include patients, carers, longterm users of services, organizations representing consumers’
interests, and members of the public, following a definition
79
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developed by the English HTA program (7). The survey found
that most INAHTA members interacted with consumers in some
aspects of their programs, although not always routinely. Involvement seemed likely to increase in the future (8).
These activities of INAHTA overlapped with the creation of
the Health Technology international Interest Sub-Group (ISG)
for Patient and Citizen Involvement in HTA. The ISG has since
developed as a strong forum for promotion of processes for
incorporating patients’ perspectives into HTAs and engaging
patients in the HTA process (9). There has been continued contact between INAHTA and the ISG.
Some more recent literature has further explored issues and
practicalities associated with the engagement of patients and the
community in the HTA process. Lee et al. have drawn attention
to issues with HTA reports that included patient-related assessments (10). There was considerable variation in how comprehensively the issues were managed and in the methodological
transparency of the reports that they reviewed, giving uncertainty as to their relevance and validity. Gagnon et al., in a
systematic review, conclude there are few published examples
of experiences of involving patients and the public in HTA (11).
They see a need to develop more systematic approaches to considering patients’ and the public’s perspectives in HTA.
Recent articles suggest there is some progress in the use
by HTA agencies of input from patients or the community but
that further evaluation of process and effectiveness is needed
(12;13). From a study based on interviews with people in HTA
agencies, Gauvin et al. found that the HTA community is moving toward greater public involvement but remains cautious and
ambivalent about the technical feasibility of public involvement, acceptability to policy makers and practitioners, and its
impact on agencies’ resources and procedures. They suggest
there is a need for rigorous evaluations to inform HTA agencies’ decisions on adoption or rejection of public involvement
practices (12).
In 2010, a follow-up survey was undertaken by INAHTA to
obtain information on whether its member agencies had changed
their approaches in involving consumers since the earlier survey.
This initiative reflected the increasing interest that has been
expressed in gathering evidence about patients’ perspectives,
and in ensuring their engagement in the HTA process (9). In
this article, we present the main findings from the survey and a
comparison with the earlier results.

Table 1. Distribution of Agencies Providing Responses, by Region

Europe
Asia
Australasia
North America
Latin America

2005, %

67
15
6
6
6

68
3
8
16
5

The questionnaire was sent to member agencies by the INAHTA secretariat in November 2010, and followed up by three
reminders. Responses were compared with those for the 2005
survey. Comparisons between the surveys for each of the questions were presented as the proportions of positive answers
received.

RESULTS
Completed survey forms returned by the following agencies:
AHTA, ASERNIP-S (Australia), LBI - HTA, GÖG (Austria),
DECIT (Brazil), CADTH, IHE (Canada), DACEHTA, MIDT
(Denmark), Finohta (Finland), HAS (France), DAHTA, GBA
(Germany), HIQA (Ireland), ICTAHC (Israel), UVT (Italy),
CNHTA (Korea), VASPVT (Lithuania), CENETEC (Mexico),
CVZ (The Netherlands), MaHTAS (Malaysia), NOKC (Norway), AHTAPol (Poland), AETS, AVALIA-T, CAHIAQ, OSTEBA (Spain), SBU (Sweden), CDE (Taiwan), HITAP (Thailand), and HIS, NETSCC, NHSC (UK).
There were differences between the two surveys in the profile of responses, due to changes in the INAHTA membership.
In 2010, there were responses from thirty-three members (63
percent response rate), compared with thirty-seven (90 percent
response rate) in 2005. Nineteen agencies (58 percent) participated in both surveys, and fourteen had joined INAHTA since
2005. Distributions of responses by region are shown in Table 1.
Twenty-two agencies (67 percent) indicated that consumers
were involved in some aspects of their HTA programs, compared
with twenty-one (57 percent) in 2005. Of those agencies that
do not currently involve consumers, 64 percent intended to do
so in the future, the same proportion as in 2005. Four agencies
provided comments on use of consumers in the preparation of
clinical practice guidelines, rather than with HTA.
Three agencies noted difficulties with involving consumers
in their programs and provided the following comments.
“The horizon scanning technology briefings we produce do
not lend themselves to the addition of consumer opinions. Consumers are represented on the panels that consider the technology briefings and prioritise them for technology appraisal. The
subsequent technology appraisal also includes consideration of
consumers and the production of an “easy-read/ understandable” version.”

METHODS
The questions and the definition of consumers used in the earlier
survey were considered to still be appropriate and were used
again for the follow up. The opportunity was taken to liaise
with the HTAi ISG on Patient/Citizen Involvement in HTA
on details of the survey. Following suggestions by the ISG,
two items were added to the survey questionnaire, covering the
inclusion of consumer perspectives in assessments.
INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 29:1, 2013
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Table 2. Approaches Used by Those Agencies That Involve Consumers in the Formulation of Assessment Topics
Type of approach
Consider suggestions made by consumers, including loosely-specified health technology topics
Use consumer input to the prioritizing process
Seek comment from consumers in refining the scope and nature of HTA projects
More detailed involvement in development of the HTA protocol, e.g. participation in committees

2010, %

2005, %

83
67
54
58

100
57
43
43

Table 3. Involvement of Consumers in Preparation of Assessments
Approach used

2010, %

2005, %

Consumers contacted to provide information or opinion on the technology being assessed 86% (Sometimes 67%, routinely: 33%)
Consumers used to provide input to analysis/ interpretation of data or to drafting of some 59% (Sometimes 62%, routinely: 38%)
sections of HTA reports
Consumers used to review protocols and/or drafts of HTA reports
59% (Sometimes 67%, routinely: 33%)
“We consider involving consumers important and relevant,
but also time consuming.”
“Patient involvement is not a routine activity, this is intended only to our major projects. Among barriers to expanding
patients’ involvement there are time and resources constraints;
difficulties in identifying appropriate consumers.”

67% (Sometimes 79%, routinely: 21%)
10% (Sometimes: 100%)
57% (Sometimes: 60%, routinely: 40%)

agency does not generally seek consumers’ input but involves
them in a few projects regarding the assessment of treatments
for psychiatric diagnoses. Approaches used by agencies are
shown in Table 2. In the 2010 survey the proportion of agencies
that considered consumers’ suggestions was lower than in 2005,
while that for each of the other (more detailed) approaches was
higher.
Responses on involvement of consumers in the preparation
of HTA reports are summarized in Table 3. In 2010, higher
proportions of agencies contacted consumers or used them for
interpretation of data and in drafting reports. Similar proportions in each survey used consumers to review protocols or
reports. Routine involvement was higher in the 2010 survey for
the first two types of task and lower for the third.
In 2010, 19 percent of agencies that involved consumers in
their programs had undertaken appraisal of such involvement,
compared with 29 percent in 2005. Of the agencies that provided
responses in 2010, one recorded numbers of reports where there
has been consumer input, three noted the type of input, and three
considered the influence of consumer input on product quality
and relevance. None of them had considered the potential for
conflicts of interest to influence consumer opinions.

Responses from Those Agencies That Involved Consumers

In both surveys, 95 percent of agencies that involved consumers
reported contact between patient organizations and their programs, and 45 percent also involved individual consumers.
Invitation from the agency remained the most frequently
used method of bringing consumers into contact with the HTA
process (90 percent). Compared with the 2005 survey, fewer
agencies accepted requests from consumers on specific topics
(59 percent versus 70 percent), while contact with the HTA
process in response to publicity on forthcoming assessments
was more common (45 percent versus 25 percent). Only a small
proportion of agencies provide a training process for consumers
who are involved in HTA programs (23 percent in 2010, 19
percent in 2005).
As before, a minority of agencies indicated that they avoided
consumer involvement in some types of assessment (24 percent
in 2005, 23 percent in 2010). Examples of where this occurred,
provided by five agencies, included commercial in confidence
evaluation of pharmaceuticals, assessments done on behalf of
some other organizations, rapid assessments, and assessments in
which there is no added value or benefit from the involvement of
consumers. Horizon scanning and rapid assessments had been
identified in the earlier survey as areas where consumers were
not involved.
In 2010, 55 percent of agencies involved consumers in the
formulation of assessment topics (67 percent in 2005). One

Preparation of Summaries for Consumers

All agencies were asked whether they prepared summaries or
versions of HTA reports that are intended to be easily understood by consumers. In the 2010 survey, 59 percent of agencies
reported providing such material compared with 49 percent in
2005. Most of those that provided summaries of reports also involved consumers in their programs (84 percent in 2010 and 71
percent in 2005). Proportions of agencies that provided different
types of summary are shown in Table 4.
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INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 29:1, 2013

Hailey et al.

DISCUSSION

Table 4. Types of HTA Summary Prepared for Consumers
Type of summary
Information in newsletters or similar format
Brief one/two page summaries
More detailed consumer summaries
‘Consumer versions’ of HTA reports

2010, %

2005, %

47
53
39
26

65
76
24
24

As in the previous survey, reported involvement of consumers in
HTA varied among INAHTA members, reflecting differences in
responsibilities and administrative arrangements. Comparison
of findings from the two surveys is tentative, given the differences in response profiles, but there appear to be indications of
increasing involvement in some activities.
A limitation in this comparison is the lower response rate
by INAHTA members in the 2010 survey. The reasons for this
decreased response are unclear. Possibly it was associated with
increases in the workload and commitments of some member
agencies. INAHTA projects rely heavily on the input from individual agencies and there are clearly limits to the time and
resources that members can offer (14).
There were also differences between the surveys in the profile of responding agencies due to changes in INAHTA membership. Review of responses from agencies that participated
in both surveys and those from single survey participants gave
some indication of similarities between the two survey populations, particularly for those agencies that involved consumers.
A feature of the 2010 survey was the increase in the proportion of agencies from Asia. It is considered unlikely that
this change would have had any substantial effect on the comparison of surveys. The Asian agencies have been influenced
by the well established HTA programs in Europe and have
adopted the most suitable values for their own settings. Attitudes toward consumer involvement have been guided by these
influences.
Of the agencies that provided responses, 67 percent involve
consumers in aspects of their HTA programs, although not always routinely, a higher proportion than that in 2005. As in 2005,
a large majority of agencies intend to involve consumers in the
future. Similar findings were reported on types of consumer
and how they are brought into contact with the HTA process. A
majority of agencies accept requests on specific topics.
As in 2005, a minority of agencies avoid involving consumers in some types of assessment. Comments from these
agencies point to practicalities in their programs that contribute
to avoidance of contact. Time and resource constraints, requirements of rapid and horizon scanning assessments and projects
undertaken in confidence all present challenges for wider patient involvement.
A much higher proportion of agencies in 2010 used consumer input to data analysis or drafting sections of HTA reports.
A small majority in each survey used consumers to review of
protocols or reports. Evaluation of consumer input to HTA programs remains uncommon.
In 2010, there was an increase in the proportion of agencies
that provide summaries of HTA reports for consumers, and also
in the proportion that involve consumers in dissemination. The
additional items included in the 2010 survey indicated limited
inclusion of consumer perspectives in assessment reports.

Involvement of Consumers in HTA Dissemination

In the 2010 survey, 42 percent of agencies involved consumer
organizations and/or individual consumers in the dissemination
of HTA materials, compared with 33 percent in 2005.

Consumer Perspectives in Assessments

In response to the additional questions in the 2010 survey, seventeen (52 percent) of the agencies advised that their HTA
reports consider consumer-reported attitudes and preferences,
and thirteen (39 percent) that their reports include a section that
assesses patient/consumer perspectives.

Comparison of Agency Responses Over Time

The 2010 responses from the sub-group of nineteen agencies
that participated in both surveys were similar to those they provided in 2005. When compared with the total responses, The
proportion of the nineteen agencies that involved consumers
was similar to that for all agencies in 2010 and higher than the
total for 2005 (65 percent versus 67 percent versus 57 percent).
The proportion of sub-group agencies that prepared summaries
for consumers was of the same order as for 2010 and higher than
2005 (63 percent versus 59 percent versus 49 percent). For those
agencies that involved consumers, responses for all three groups
were almost identical for involvement of patient organizations
and methods of contact, involvement in topic formulation and
in review of protocols and draft reports. The proportion of subgroup agencies that involve individual consumers was somewhat higher than the totals for both surveys (58 percent versus
46 percent versus 48 percent).
Responses from agencies that participated in only one survey were also compared. The proportion of the fourteen agencies from the 2010 survey that involved consumers was higher
than for the eighteen that participated only in 2005 (71 percent
versus 50 percent). The proportion of agencies that prepared
summaries for consumers was also higher in 2010 than 2005
(50 percent versus 33 percent). For those agencies that involved
consumers, responses for both groups were almost identical
for involvement of patient organizations and of individual consumers, and methods of contact, involvement in topic formulation and in review of protocols and draft reports.
INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 29:1, 2013
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Overall, the 2010 survey suggests that there is a trend to
increased involvement of consumers by INAHTA members in
their programs, continuing the generally positive response found
in the earlier survey.
There appear to be similar issues to those for HTA in the
involvement of consumers in the development of guidelines.
A systematic review of patient and public involvement programs (PPIPs) in developing clinical practice guidelines found
that of seventy-one descriptive reports twenty-three reported using PPIPs to “incorporate patients’ values, preferences, knowledge, or perspectives in CPG recommendations” (15). Eccles
et al. note that of the seventy-one reports only twenty-eight
were dealing with consumers within the guideline development
group itself and only twenty-nine were dealing with consumers
involved in crafting recommendations (16). Barriers to consumer involvement that were identified resemble those that have
emerged for health research and HTA. They included the discrepancy between the views of patients and experts, challenges
of recruitment, obtaining representative input, consumers’ lack
of familiarity with technical issues and the degree of work/time
involved. Eccles et al. comment that there are still few analytical
empirical accounts of attempts to involve consumers in guideline development, and no robust evaluations of the effectiveness
of different methods.

Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand
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POLICY IMPLICATIONS
The involvement of consumers by many INAHTA agencies offers the potential to broaden the perspective of assessments
and of the advice provided to decision makers. It also gives
stakeholders further opportunity to gain information on health
technologies that may help their own inputs to the policy process. There seems to be a trend toward increased involvement,
but there are also barriers to wider routine participation of consumers in the HTA processes of these agencies.
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